New Science Ventures

New Science Ventures (NSV) is a prominent venture capital firm headquartered in Greenwich, Connecticut, with a dedicated focus on pioneering companies within the life sciences and information technology sectors. Established with a vision to back disruptive technologies, NSV leverages deep industry expertise to identify and nurture businesses poised for significant growth and market impact. Their investment philosophy centers on supporting companies that address unmet needs or offer innovative solutions across their core domains.

Within life sciences, NSV targets a broad spectrum of opportunities, including biopharmaceuticals, medical devices, diagnostics, and research tools, seeking out advancements that promise to transform healthcare. In the information technology space, their interests span artificial intelligence, big data analytics, cloud computing, cybersecurity, and enterprise software, focusing on solutions that drive efficiency and innovation across industries. NSV typically engages with companies from early to growth stages, providing not only capital but also strategic guidance and operational support to help portfolio companies scale.

NSV is known for its substantial financial commitments. Their typical initial investment, or first check, ranges from approximately $5 million to $20 million, demonstrating their capacity to provide meaningful early-stage capital. The firm has a strong track record of raising significant funds, with New Science Ventures IV, for instance, closing at $300 million, contributing to their total assets under management exceeding $1 billion across all funds.

The firm's extensive portfolio includes investments in over 60 companies since its inception, reflecting a consistent and active presence in the venture landscape. Their approach emphasizes long-term partnerships, working closely with management teams to navigate complex market dynamics and achieve successful outcomes. NSV's commitment to fostering scientific and technological breakthroughs positions them as a key player in advancing innovation within critical sectors.